- Q4 2023 NeuroMetrix Inc Earnings Call TranscriptFeb 22, 2024$2.94 (-7.26%)Earnings
- NeuroMetrix Inc at Emerging Growth Conference (Virtual) TranscriptNov 01, 2023
- Q3 2023 NeuroMetrix Inc Earnings Call TranscriptOct 26, 2023$4.32 (-19.10%)Earnings
- NeuroMetrix Inc at Emerging Growth Conference (Virtual) TranscriptOct 04, 2023
- Q2 2023 NeuroMetrix Inc Earnings Call TranscriptJul 27, 2023$7.28 (-6.97%)Earnings
- Q1 2023 NeuroMetrix Inc Earnings Call TranscriptMay 03, 2023$8.48 (-23.74%)Earnings
- Q4 2022 NeuroMetrix Inc Earnings Call TranscriptFeb 23, 2023$14.24 (+4.71%)Earnings
- Q3 2022 NeuroMetrix Inc Earnings Call TranscriptOct 20, 2022$15.12 (-10.43%)Earnings
- Q2 2022 NeuroMetrix Inc Earnings Call TranscriptJul 21, 2022$29.36 (-4.92%)Earnings
- Q1 2022 NeuroMetrix Inc Earnings Call TranscriptApr 26, 2022$26.64 (-11.20%)Earnings
- Q4 2021 NeuroMetrix Inc Earnings Call TranscriptJan 27, 2022$32.72 (-7.47%)Earnings
- Q3 2021 NeuroMetrix Inc Earnings Call TranscriptOct 21, 2021$66.8 (-8.24%)Earnings
- Q2 2021 NeuroMetrix Inc Earnings Call TranscriptJul 22, 2021$197.84 (+18.89%)Earnings
- Q1 2021 NeuroMetrix Inc Earnings Call TranscriptApr 22, 2021$23.6 (-2.64%)Earnings
- Q4 2020 NeuroMetrix Inc Earnings Call TranscriptJan 28, 2021$31.52 (-10.45%)Earnings
- Q3 2020 NeuroMetrix Inc Earnings Call TranscriptOct 22, 2020$12.64 (-3.66%)Earnings
- Q2 2020 NeuroMetrix Inc Earnings Call TranscriptJul 23, 2020$15.68 (-3.92%)Earnings
- Q1 2020 NeuroMetrix Inc Earnings Call TranscriptApr 23, 2020$22.96 (-6.21%)Earnings
- Q4 2019 NeuroMetrix Inc Earnings Call TranscriptJan 27, 2020$28.16 (-25.89%)Earnings
- Q3 2019 NeuroMetrix Inc Earnings Call TranscriptOct 17, 2019$23.92 (-6.68%)Earnings
- Q2 2019 NeuroMetrix Inc Earnings Call TranscriptJul 18, 2019$30.72 (-16.10%)Earnings
- Q1 2019 NeuroMetrix Inc Earnings Call TranscriptApr 25, 2019$65.7 (-7.20%)Earnings
NeuroMetrix Inc at Emerging Growth Conference (Virtual) Transcript
Dr. Shai Gozani, Chairman and CEO of NeuroMetrix, Inc. For business update, NeuroMetrix trades on the Nasdaq under the symbol NURO and is a neuromodulation company developing novel treatments for chronic pain syndromes. Welcome back, Doctor. How are you today?
I'm great. Thank you very much, Ana. We appreciate the opportunity to update today. So just very briefly, this is our forward-looking statements. A disclaimer, please take a look at our recently filed Qs as well as our 10-K for assessment of and list of risk factors.
So just as a reminder, NeuroMetrix is a Boston-based medical device company. Our mission is to improve the lives of patients with chronic pain through neuromodulation devices. And just diving into that a little bit, we focus on intractable chronic pain, which are those forms of chronic pain that really are resistant to typical treatments.
We believe that we are well positioned based on our recent clinical and regulatory
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)